Vericel Corporation (NASDAQ:VCEL) HEFFX Issues Strong Buy
The global regenerative medicine market size is projected to advance at a substantial rate in the coming years thanks to the increasing prevalence of chronic diseases and genetic disorders, rising number of regenerative medicine companies across the world, surging government investments in regenerative medicine research, and technological advancements in the stem cell therapy and tissue engineering areas.
The discipline of medicine that focuses on the regeneration or replacement of human cells, tissues, and organs for re-establishing normal functionality of the body is referred to as regenerative medicine. The renewal or replacement of cells in human tissues and organs are often attained by encouraging the body’s own cells to heal or by treating with cells and tissues that are laboratory grown.
Cell-based and acellular are two kinds of regenerative medicines, between which, the cell-based regenerative medicine held the larger regenerative medicine market share in the past. This was due to the rising demand for cell-based immunotherapies. The type is further divided into autologous and allogenic.
The different kinds of therapy included in the industry are gene therapy, immunotherapy, cell therapy, and tissue engineering. Among these, the immunotherapy category is expected to register the fastest growth in the coming years in the regenerative medicine market.
Vericel Corporation is an integrated, commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function.
The Company operates through the research, product development, manufacture and distribution of cellular therapies for use in the treatment of specific diseases.. Its autologous cell therapy products include Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns.
The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.
Shayne Heffernan Trade Idea
“We predict the future price of Vericel Corporation will come in around $21.25 which will give the stock a price increase of +50.07%.
Overall, the bias in prices is: Upwards.
Note: this chart shows extraordinary price action to the upside.
The projected upper bound is: 15.60.
The projected lower bound is: 12.83.
The projected closing price is: 14.21.
A black body occurred (because prices closed lower than they opened).
During the past 10 bars, there have been 4 white candles and 6 black candles for a net of 2 black candles. During the past 50 bars, there have been 28 white candles and 22 black candles for a net of 6 white candles.
An inverted hammer occurred. If this occurs during a downtrend (which appears to be the case with VERICEL CORP ORD) it implies a reversal. Look for a confirmation of the reversal on the bar.
A long upper shadow occurred. This is typically a bearish signal (particularly when it occurs near a high price level, at resistance level, or when the security is overbought).
A shooting star occurred (a shooting star has a small real body near the bottom of the candle and a long upper shadow). During an uptrend the long upper shadow indicates that the bears are gaining control and a top may occur.
A spinning top occurred (a spinning top is a candle with a small real body). Spinning tops identify a session in which there is little price action (as defined by the difference between the open and the close). During a rally or near new highs, a spinning top can be a sign that prices are losing momentum and the bulls may be in trouble.
Three black candles occurred in the last three days. Although these candles were not big enough to create three black crows, the steady downward pattern is bearish.
Momentum is a general term used to describe the speed at which prices move over a given time period. Generally, changes in momentum tend to lead to changes in prices. This expert shows the current values of four popular momentum indicators.
One method of interpreting the Stochastic Oscillator is looking for overbought areas (above 80) and oversold areas (below 20). The Stochastic Oscillator is 21.8340. This is not an overbought or oversold reading. The last signal was a sell 3 period(s) ago.
Relative Strength Index (RSI)
The RSI shows overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 48.07. This is not a topping or bottoming area. A buy or sell signal is generated when the RSI moves out of an overbought/oversold area. The last signal was a sell 19 period(s) ago.
Commodity Channel Index (CCI)
The CCI shows overbought (above 100) and oversold (below -100) areas. The current value of the CCI is -69. This is not a topping or bottoming area. The last signal was a buy 8 period(s) ago.
The Moving Average Convergence/Divergence indicator (MACD) gives signals when it crosses its 9 period signal line. The last signal was a sell 17 period(s) ago.
Rex Takasugi – TD Profile
VERICEL CORP ORD closed down -0.260 at 14.120. Volume was 89% below average (consolidating) and Bollinger Bands were 70% narrower than normal.
Open High Low Close Volume 14.170 14.475 14.090 14.120 80,787
Technical Outlook Short Term: Neutral Intermediate Term: Bearish Long Term: Bearish
Moving Averages: 10-period 50-period 200-period Close: 14.49 13.18 15.39 Volatility: 31 75 85 Volume: 537,328 713,674 611,364
Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.
VERICEL CORP ORD is currently 8.3% below its 200-period moving average and is in an downward trend. Volatility is low as compared to the average volatility over the last 10 periods.
Our volume indicators reflect volume flowing into and out of VCEL.O at a relatively equal pace (neutral). Our trend forecasting oscillators are currently bearish on VCEL.O and have had this outlook for the last 9 periods. our momentum oscillator has set a new 14-period low while the security price has not. This is a bearish divergence.
We invite you to try out any MetaStock product (including Add-Ons) for 30 days. If you are not convinced that it helps you make more accurate, educated trading decisions, just return it to us within the 30 days for a refund of the purchase price. It’s that simple. This policy does not apply to subscriptions.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of the Nasdaq Stock Market. Trading
Trading and investing carries a HIGH LEVEL OF RISK, you could lose some or all of your investment. Trading commodities or any other financial instrument may not be suitable for all traders. Before deciding to trade, you should carefully consider your investment objectives, level of experience, and risk appetite. We accept no liability for any losses or damages you may incur—this means that you alone are responsible for your actions in any trading or investing activities.